相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
Michael G. Strainic et al.
NATURE IMMUNOLOGY (2013)
International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
Andreas Klos et al.
PHARMACOLOGICAL REVIEWS (2013)
Novel roles of complement in T effector cell regulation
Peter S. Heeger et al.
IMMUNOBIOLOGY (2012)
FELASA guidelines for the accreditation of health monitoring programs and testing laboratories involved in health monitoring
Werner Nicklas et al.
LAB ANIMAL (2010)
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma
Stephane Lajoie et al.
NATURE IMMUNOLOGY (2010)
Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis
Rudolf Mennigen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Role of the C5a Receptor (C5aR) in Acute and Chronic Dextran Sulfate-Induced Models of Inflammatory Bowel Disease
Kay Johswich et al.
INFLAMMATORY BOWEL DISEASES (2009)
Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-induced Colitis
Philip Alex et al.
INFLAMMATORY BOWEL DISEASES (2009)
CD4 T-cell differentiation and inflammatory bowel disease
Lauren A. Zenewicz et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells
Michael G. Strainic et al.
IMMUNITY (2008)
Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis
Terez Shea-Donohue et al.
INNATE IMMUNITY (2008)
Suppression of experimental colitis by intestinal mononuclear phagocytes
Joseph E. Qualls et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium
K. Kobayashi et al.
JOURNAL OF PATHOLOGY (2006)
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease
TM Woodruff et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice:: correlation between symptoms and inflammation
S Melgar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: Role for complement in inflammatory bowel disease
F Lin et al.
JOURNAL OF IMMUNOLOGY (2004)
Biologics in inflammatory bowel disease: how much progress have we made?
WJ Sandborn et al.
GUT (2004)
Refined histopathologic scoring system improves power to detect colitis QTL in mice
A Bleich et al.
MAMMALIAN GENOME (2004)
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease
TM Woodruff et al.
JOURNAL OF IMMUNOLOGY (2003)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice
Y Naito et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
C Banks et al.
JOURNAL OF PATHOLOGY (2003)
Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis
KJ Myers et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy
SM Drouin et al.
JOURNAL OF IMMUNOLOGY (2002)
The CXC chemokine murine monokine induced by IFN-γ (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo
MK Park et al.
JOURNAL OF IMMUNOLOGY (2002)
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease
B von Lampe et al.
GUT (2000)
Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency
B Egger et al.
DIGESTION (2000)
分享论文
